Abstract
The clinical presentation of Cogan’s syndrome has been classified as typical and atypical. Like other forms of ocular vasculitis, Cogan’s syndrome has been found to have autoimmune origins with antibodies against the cornea, inner ear, and endothelial antigens. Antineutrophil cytoplasmic antibody (ANCA) and rheumatoid factor (RF) have been associated with Cogan’s syndrome as well as ocular-involving vasculitides not as strongly associated with the audiovestibular manifestations such as granulomatosis with polyangiitis and rheumatoid arthritis. The mainstay of therapy has been corticosteroids although other methods have been described in recalcitrant disease and to prevent development of systemic sequelae.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Cogan DG. Syndrome of non-syphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144–9.
Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine. 1980;59:426–41.
Vollersten R. Vasculitis and Cogan’s syndrome. Rheum Dis Clin N Am. 1990;16:433–8.
Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet. 2002;360:915–21.
Van Doornum S, McColl G, Walter M, et al. Prolonged prodrome, systemic vasculitis, and deafness in Cogan’s syndrome. Ann Rheum Dis. 2001;60:69–71.
Cheson BD, Bluming AZ, Alroy J. Cogan’s syndrome: a systemic vasculitis. Am J Med. 1976;60:549–55.
Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology. 2004;43:1007–15.
Branislava I, Marijana T, Nemanja D, et al. Atypical Cogan’s syndrome associated with coronary disease. Chin Med J. 2011;124:3192–4.
Gaubitz M, Lubben B, Seidel M, et al. Cogan’s syndrome: Organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol. 2001;19:463–9.
Gasparovic H, Djuric Z, Bosnic D, et al. Aortic root vasculitis associated with Cogan’s syndrome. Ann Thorac Surg. 2011;92:340–1.
Hautefort C, Loundon N, Montchilova M, et al. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477–9.
Lepur D, Vranjican Z, Himbele J, et al. Chlamydia pneumonia infection as a trigger for a Cogan’s syndrome. J Infect. 2006;52:223–6.
Pagnini I, Zannin ME, Vittadello F, et al. Clinical features and outcome of Cogan Syndrome. J Pediatr. 2012;160:303–7. Review of the pediatric implications of Cogan syndrome with focus on different manifestations in children with major impact on function.
Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81:483–8.
Darougar S, John AC, Viswalingam M, et al. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with ontological and cardiovascular lesions. Br J Ophthalmol. 1978;62:709–14.
Ljungstrom L, Franzen C, Schlaug M, et al. Reinfection with Chlamydia pneumonia may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis Suppl. 1997;104:37–40.
Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997;65:4832–5.
Helmchen C, Arbusow V, Jager L, et al. Cogan’s syndrome: clinical significance of antibodies against the inner ear and cornea. Acta Otolaryngol (Stockh). 1999;119:528–36.
Hughes GB, Kinney SE, Barna BP, et al. Autoimmune reactivity in Cogan’s syndrome: a preliminary report. Otolaryngol Head Neck Surg. 1983;91:24–32.
Majoor MH, Albers FW, van der Gaag R, et al. Corneal autoimmunity in Cogan’s syndrome? Report of two cases. Ann Otol Rhinol Laryngol. 1992;101:679–84.
Garcia Callejo FJ, Costa Alcacer I, Blay Galaud L, et al. Inner ear autoimmune disorder. Cogan’s syndrome. An Esp Pediatr. 2001;55:87–91.
Bonaguri C, Orsoni J, Russo A, et al. Cogan’s Syndrome: Anti-Hsp70 Antibodies are a serological marker in the typical form. IMAJ. 2014;16:285–8. Important autoantibody finding that may serve as a serological marker for typical Cogan’s syndrome.
Ikeda M, Okazaki H, Minota S. Cogan’s syndrome with antineutrophil cytoplasmic autoantibody. Ann Rheum Dis. 2002;61:761–2.
Tarney CM, Wilson K, Sewell MF. Cogan Syndrome in pregnancy. Obstet Gynecol. 2014;124:428–31.
Tervaert JW, Mulder L, Stegeman C, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener’s granulomatosis and other inflammatory disorders. Ann Rheum Dis. 1993;52:115–20.
Yamanishi Y, Ishioka S, Takeda M, et al. Atypical Cogan’s syndrome associated with antineutrophil cytoplasmic autoantibodies. Br J Rheumatol. 1996;35:601–3.
Suzuki M, Arimura Y, Minoshima S, et al. A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan’s syndrome. Nippon Jinzo Gakkai Shi. 1996;38:423–7.
Brijker F, Magee CC, Tervaert J, et al. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol. 1999;52:344–51.
Lee LY, Akhtar MM, Kirresh O, Gibson T: Interstitial keratitis and sensorineural hearing loss as a manifestation of rheumatoid arthritis: clinical lessons from a rare complication. BMJ Case Rep 2012.
Harper SL, Letko E, Samson CM, et al. Wegener’s Granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001;28:1025–32.
Bakthavachalam S, Driver MS, Cox C, et al. Hearing loss in Wegener’s granulomatosis. Otol Neurotol. 2004;25:833–7.
Sriskandarajah V, Bansal RA, Yeoh R, Bansal AS. Early intervention in localized Wegener’s granulomatosis with sensorineural hearing loss preserves hearing. Am J Audiol. 2012;21:121–6.
Gran JT, Nordvag BY, Storesund B. An overlap syndrome with features of atypical Cogan syndrome and Wegener’s granulomatosis. Scand J Rheumatol. 1999;28:62–4.
Finkielman JD, Lee AS, Hummel AM, et al. ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med. 2007;120:643.e9–14.
Zlatanovic G, Veselinovic D, Cekic S, et al. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci. 2010;10:323–7.
Fujita M, Igarachi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140:808–13.
Knox Cartwright NE, Tole DM, Georgoudis P, Cook SD. Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison. Cornea. 2014;33:27–31. Important review showing that current therapeutic interventions are improving outcomes in immune mediated ocular disease.
Takatsu M, Higaki M, Kinoshita H, et al. Ear involvement in patients with Rheumatoid Arthritis. Otol Neurotol. 2005;26:755–61.
Pascual-Ramos V, Contreras-Yanez I, Enriquez L, et al. Hearing impairment in a tertiary-care-level population of Mexican rheumatoid arthritis patients. J Clin Rheumatol. 2012;18:393–8.
Pascual-Ramos V, Contreras-Yanez I, Rivera-Hoyos P, et al. Cumulative disease activity predicts incidental hearing impairment in patient with rheumatoid arthritis. Clin Rheumatol. 2014;33:315–21.
Deane KD. Preclinical rheumatoid arthritis (autoantibodies): an updated review. Curr Rheumatol Rep. 2014;16:419.
Kessel A, Vadasz Z, Toubi E. Cogan syndrome—Pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2014;13:351–4. A nice review of Cogan’s syndrome stressing more of the plethora of systemic findings associated with the disease.
Beccastrini E, Emmi G, Squatrito D, et al. Infliximab and Cogan’s syndrome. Clin Otolaryngol. 2010;35:441–2.
Shahid FL, Mukherjee R, Knapp C. Cogan’s Syndrome associated with orbital inflammation. Orbit. 2013;32:206–7.
Shibuya M, Fijio K, Morita K, et al. Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Mod Rheumatol. 2013;23:577–81.
Bovo R, Ciorba A, Trevisi P, et al. Cochlear implant in Cogan syndrome. Acta Otolaryngol (Stockh). 2011;131:494–7.
Compliance with Ethics Guidelines
Conflict of Interest
Gabriela M. Espinoza and Angela Prost declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Vasculitis
Rights and permissions
About this article
Cite this article
Espinoza, G.M., Prost, A. Cogan’s Syndrome and Other Ocular Vasculitides. Curr Rheumatol Rep 17, 24 (2015). https://doi.org/10.1007/s11926-015-0499-y
Published:
DOI: https://doi.org/10.1007/s11926-015-0499-y